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Abstract
Common variants of the transcription factor 7-like 2 (TCF7L2) gene have been found to be associated with type 2 diabetes in 
different ethnic groups. The Japanese-Brazilian population has one of the highest prevalence rates of diabetes. Therefore, the aim 
of the present study was to assess whether two single-nucleotide polymorphisms (SNPs) of TCF7L2, rs7903146 and rs12255372, 
could predict the development of glucose intolerance in Japanese-Brazilians. In a population-based 7-year prospective study, 
we genotyped 222 individuals (72 males and 150 females, aged 56.2 ± 10.5 years) with normal glucose tolerance at baseline. 
In the study population, we found that the minor allele frequency was 0.05 for SNP rs7903146 and 0.03 for SNP rs12255372. 
No significant allele or genotype association with glucose intolerance incidence was found for either SNP. Haplotypes were 
constructed with these two SNPs and three haplotypes were defined: CG (frequency: 0.94), TT (frequency = 0.027) and TG 
(frequency = 0.026). None of the haplotypes provided evidence for association with the incidence of glucose intolerance. Despite 
no associations between incidence of glucose intolerance and SNPs of the TCF7L2 gene in Japanese-Brazilians, we found that 
carriers of the CT genotype for rs7903146 had significantly lower insulin levels 2 h after a 75-g glucose load than carriers of the 
CC genotype. In conclusion, in Japanese-Brazilians, a population with a high prevalence of type 2 diabetes, common TCF7L2 
variants did not make major contributions to the incidence of glucose tolerance abnormalities.
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Population groups with defined characteristics have 
been studied to assess the role of environmental and ge-
netic factors in the etiology of non-communicable diseases 
such as diabetes mellitus. A previous study on Japanese-
Brazilians showed that 22.6% of this population had diabetes 
in the first phase of the study. In the second phase of the 
study, 7 years later, this prevalence had increased to 36.1%, 
being one of the highest worldwide (1). This situation could 
be reflecting the strong genetic susceptibility of this popula-
tion associated with an unfavorable environment.
It is well known that type 2 diabetes has a strong genetic 
background. At present, it is not well understood how many 
genes are involved and what their relative contributions are 
to the development of diabetes mellitus. In 2006, Grant et 
al. (2) identified a microsatellite marker (DG10S478) in the 
transcription factor 7-like 2 gene (TCF7L2) that showed 
strong association with type 2 diabetes in Icelandic indi-
viduals, with replication in Danish and US cohorts. The 
single-nucleotide polymorphisms (SNPs) with the strongest 
correlation with DG10S478 were rs7903146, rs12255372, 
rs7901695, rs11196205, and rs7895340. After this initial 
finding many other studies have found consistent asso-
ciations between TCF7L2 variants and type 2 diabetes in 
populations of different ethnic groups (3-10).
The TCF7L2 gene product is a transcription factor 
involved in the Wnt signaling pathway. This pathway is 
considered to be critical for multiple developmental and 
growth-regulating processes of the cell (11). Reduced 
insulin secretion might be the essential component by 
which TCF7L2 polymorphisms increase the risk of diabe-
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tes. However, the precise molecular mechanism(s) remain 
to be elucidated. Since in a previous study Yi et al. (12) 
described the role of TCF7L2 in the regulation of the pro-
glucagon gene, which encodes glucagon, glucagon-like 
peptide 1 (GLP-1) and GLP-2, it had been suggested 
that the association with type 2 diabetes may involve an 
impaired incretin effect (2). Despite the role of TCF7L2 
in the transcriptional regulation of the proglucagon gene, 
plasma GLP-1 concentrations during oral glucose tolerance 
or mixed meal tests were not significantly influenced by 
the TCF7L2 polymorphisms (13,14). Therefore, the lower 
incretin-mediated insulin response seems to be the result 
of an under-responsiveness of pancreatic β-cells rather 
than a reduction in GLP-1 secretion (14,15).
The aim of the present study was to assess whether two 
SNPs of the TCF7L2 gene, rs7903146 and rs12255372, 
could predict the development of glucose intolerance in a 
Japanese-Brazilian population. 
Material and Methods
The study population consisted of individuals recruited 
from the Japanese-Brazilian Diabetes Study Group, a sur-
vey designed to estimate the prevalence and incidence of 
diabetes and associated diseases in a Japanese-Brazilian 
population living in Bauru, São Paulo State, Brazil. Details 
on the selection and recruitment of the sample population 
have been previously reported (1). Briefly, the first phase of 
the study involved all individuals aged 40-79 years from the 
first generation (Issei) and a random sample (one third plus 
20%) of those from the second generation (Nisei) from the 
same age group. A total of 647 individuals were examined 
and submitted to an oral glucose tolerance test (OGTT). 
In the second phase of the study, seven years later, the 
glucose tolerance status of 394 subjects was reexamined 
(follow-up rate: 61%). For the present study, we enrolled 
222 individuals (72 males and 150 females aged 56.2 
± 10.5 years) with normal glucose tolerance in the first 
phase of the study and suitable DNA samples. 
The glucose tolerance status was based on the 1999 
WHO criteria (16). Plasma glucose was determined 
by the glucose-oxidase method. Insulin and proinsulin 
were determined by a monoclonal antibody-based im-
munofluorimetric assay (17,18). Homeostasis model 
assessment (HOMA) was used to assess β-cell function 
(HOMA-β) and insulin resistance (HOMA-IR) (19). 
Genotyping TCF7L2 rs7903146 and rs12255372
Blood samples were obtained from each subject 
and genomic DNA was extracted from peripheral blood 
leukocytes using a commercial kit (Puregene DNA 
Isolation Kit, Gentra System, USA). Both SNPs were 
genotyped using TaqMan SNP Genotyping Assays 
(Applied Byosystem, USA) according to manufacturer 
instructions. The genotyping success rate was 96.4% 
for rs7903146 and 92.8% for rs12255372. The quality con-
trol for these assays was assessed by direct sequencing 
of 10 samples with different genotypes. The concordance 
observed between genotyping assays was 100%.
This study was approved by the Ethics Committee of 
Escola Paulista de Medicina, Universidade Federal de São 
Paulo, and all subjects gave written informed consent to 
participate.
Statistical analysis
All statistical analyses were performed using the Stata 
version 9.1 software (Statacorp, USA). Continuous data 
are reported as means ± SD unless otherwise specified. 
Variables with skewed distributions were log transformed 
to satisfy assumptions of normality and back-transformed 
values are shown. The Student t-test, χ2 or Fisher test was 
used as appropriate. Haplotype frequency, Hardy-Weinberg 
equilibrium, and linkage disequilibrium statistics were ob-
tained using the Haploview software.
Results
The comparison of subjects’ baseline characteristics 
showed a worse metabolic profile among those who 
progressed to glucose intolerance at the 7-year follow-up 
(Table 1). Subjects who continued to have normal glucose 
tolerance had lower mean values of body mass index, waist 
circumference, fasting plasma glucose concentrations, and 
HOMA-IR.
Of the 214 individuals genotyped for the rs7903146 
variant, 191 (89%) had the CC genotype and 23 (11%) had 
the CT genotype. Of the 206 individuals genotyped for the 
rs12255372 variant, 192 (93%) had the GG genotype and 
14 (7%) had the GT genotype. The genotypic distribution 
of both SNPs was in Hardy-Weinberg equilibrium. The 
minor allele frequency of SNP rs7903146 was 0.05 and 
Table 1. Baseline characteristics of individuals who continued to have 
normal glucose tolerance (NGT) and individuals who progressed to 
glucose intolerance.
Characteristics NGT 
(N = 50)
Glucose intolerance 
(N = 172)
Age (years) 58.4 ± 11.0 55.5 ± 10.5
Body mass index (kg/m²) 22.7 ± 3.0 24.6 ± 3.6*
Waist circumference (cm) 79.4 ± 11.0 86.0 ± 9.0*
Fasting plasma glucose (mg/dL) 87.8 ± 7.3 92.4 ± 8.6* 
HOMA-β 47.9 ± 34 68.7 ± 97.5
HOMA-IR 0.67 ± 0.8 1.18 ± 1.8*
Data are reported as means ± SD. HOMA-β = homeostasis model 
assessment of β-cell function; HOMA-IR = homeostasis model as-
sessment of insulin resistance.  *P < 0.05 compared to individuals 
with normal glucose tolerance (Student t-test).
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that of SNP rs12255372 was 0.03. The genotype and al-
lele frequencies of both SNPs of subjects who continued 
to have normal glucose tolerance and the ones who pro-
gressed to glucose intolerance are shown in Table 2. No 
significant allele or genotype association was found with 
the incidence of glucose intolerance. Linkage disequilibrium 
analysis showed that the alleles of the two poly-
morphisms were moderately associated (D’ = 
0.76). Haplotypes were constructed with these 
SNPs and three haplotypes were defined: CG 
(frequency = 0.94), TT (frequency = 0.027) and 
TG (frequency = 0.026). None of the haplotypes 
provided evidence for an association with the 
incidence of glucose intolerance (Table 3). 
The relationship of rs7903146 and 
rs12255372 with β-cell function measures 
was assessed at baseline. Carriers of the CT 
genotype for rs7903146 had lower 2-h insulin 
levels after the OGTT than carriers of the CC 
genotype (CC = 138.30 ± 133.73 pmol/L, CT = 
81.40 ± 78.70 pmol/L, P = 0.02). Also, a trend 
towards lower 2-h insulin levels was observed 
in GT carriers of rs12255372 (GG = 130.40 ± 
125.90 pmol/L, GT = 77.00 ± 75.44 pmol/L, P 
= 0.07; Table 4).
Discussion
In this study, we tested for associations 
between incidence of glucose intolerance 
and SNPs of the TCF7L2 gene in a cohort 
of Japanese-Brazilians. Although TCF7L2 
variants have been consistently associated 
with an increased risk for type 2 diabetes in 
diverse populations (3-10), the present study 
showed that the presence of SNPs rs7903146 
and rs12255372 did not predict glucose intolerance in 
Japanese-Brazilians. Guo et al. (20), in a large study group 
of Pima Indians, also did not find an association between 
TCF7L2 polymorphisms and type 2 diabetes. Also, Florez 
et al. (21) reported associations of the TCF7L2 gene with 
increased risk of developing diabetes in the Diabetes Pre-
Table 2. Genotype and allele frequencies of single-nucleotide polymorphisms 
(SNPs) rs7903146 and rs12255372 of subjects who remained with normal glu-
cose tolerance (NGT) and those who progressed to glucose intolerance.
SNP Genotype  Allele
rs7903146 CC CT C T
NGT 44 (89.8) 5 (10.2) 93 (94.9) 5 (5.1)
Glucose intolerance 147 (89.1) 18 (10.9) 312 (94.5) 18 (5.5)
rs12255372 GG GT G T
NGT 44 (93.6) 3 (6.38) 91 (96.8) 3 (3.2)
Glucose intolerance 148 (93.1) 11 (6.92) 307 (96.5) 11 (3.5)
Data are reported as number (N) with percent in parentheses. All P values 
were >0.05 when comparing NGT and glucose intolerance (Fisher exact test).
Table 3. Haplotype frequencies of subjects who remained with normal glucose 
tolerance (NGT) and those who progressed to glucose intolerance.
Haplotype rs7903146, rs12255372 Glucose intolerance NGT
CG 0.940 0.939
TT 0.027 0.025
TG 0.026 0.026
All P values were >0.05 when comparing NGT and glucose intolerance (chi-
square test).
Table 4. Baseline characteristics by genotypes for the TCF7L2 single-nucleotide polymor-
phisms of the subjects studied.
Characteristics rs7903146 rs12255372
CC (N = 191) CT (N = 23) GG (N = 192) GT (N = 14)
Age (years) 56.4 ± 9.9 57.4 ± 10.5 56.5 ± 9.9 57.4 ± 11.2
Body mass index (kg/m²) 24.3 ± 3.6 23.5 ± 3.2 24.3 ± 3.7 23.1 ± 2.5
Fasting glucose (mg/dL) 91.8 ± 8.5 88.8 ± 9.4 92.0 ± 8.4 88.5 ± 9.8
2-h glucose (mg/dL) 100.8 ± 20.8 92.1 ± 23.3 99.1 ± 21.2 96.2 ± 26.3
Fasting insulin (pmol/L) 15.8 ± 13.1 10.0 ± 8.0 14.4 ± 11.8 8.1 ± 6.3
2-h insulin (pmol/L) 138.3 ± 133.7 81.4 ± 78.7* 130.4 ± 125.9 77.0 ± 75.4
Fasting proinsulin (pmol/L) 3.3 ± 2.2 2.9 ± 2.0 3.4 ± 2.3 2.5 ± 1.8
2-h proinsulin (pmol/L) 13.1 ± 10.6 12.6 ± 10.4 13.1 ± 10.6 12.2 ± 10.2
Data are reported as means ± SD. *P < 0.05, CT compared to CC (Student t-test).
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vention Program cohort. However, in the Asian subgroup 
analysis there were no associations of the polymorphisms 
with type 2 diabetes. Our findings suggest that this particular 
population has a different set of genetic risk factors for type 
2 diabetes. In this scenario, this population may be used 
as a resource to identify new genetic risk factors for this 
complex phenotype.
The underlying mechanism by which intronic varia-
tions of the TCF7L2 gene without obvious function in 
gene regulation contribute to the development of type 2 
diabetes in most populations remains to be elucidated. 
One possibility is that the association with type 2 diabetes 
reflects a linkage disequilibrium with more distant functional 
alleles. A difference in linkage disequilibrium pattern with 
a putative functional variant in Japanese-Brazilians may 
be an explanation for the lack of association between the 
SNPs studied and the incidence of glucose intolerance in 
this population. Similarly, Chang et al. (22) studying a Han 
Chinese population, found no associations between SNPs 
rs7903146 and rs12255372 and type 2 diabetes, but identi-
fied a novel risk-conferring SNP, rs290487.
The frequencies of minor alleles of the two SNPs, which 
are the high-risk alleles for diabetes in most populations, 
were very low in this Japanese-Brazilian population. Simi-
larly, Horikoshi et al. (10) and Chang et al. (22), studying 
samples of Japanese and Chinese populations, found that 
the minor allele frequencies of these SNPs were lower 
than those previously reported for Caucasians, meaning 
that studies on Asians have less power. In fact, one limita-
tion of the present study was the relatively small statistical 
power derived from both low minor allele frequency and 
small sample size. Nonetheless, if one analyzes the point 
estimate of risk (in our case the presence of a T allele was 
associated with an RR of only 1.01, 95%CI = 0.81-1.28) 
it is interesting to observe that there was no tendency of 
association in our sample. Indeed, in most studies able to 
show an association between the T allele of this SNP and 
the prevalence or incidence of type 2 diabetes, the pres-
ence of the risk allele was associated with a 30% increased 
risk. This suggests that other factors are responsible for 
not detecting an association than only a reduced statistical 
power in the present study.
Despite the lack of association between incidence of 
glucose intolerance and SNPs of TCF7L2 gene in Japa-
nese-Brazilians, we found that carriers of the CT genotype 
for rs7903146 had lower insulin levels at 2 h after a 75-g 
glucose load than carriers of the CC genotype. Saxena et 
al. (6), studying non-diabetic individuals, found a significant 
reduction in the area under the curve for insulin during the 
OGTT in homozygous carriers of the rs7903146 risk allele. 
Also, Pilgaard et al. (13) found in young healthy men a 
reduced 24-h insulin concentration and a reduced insulin 
secretion during a mixed meal in carriers of the T allele for 
rs7903146. These findings indicate that TCF7L2 variants 
may increase diabetes risk by reduced insulin secretion 
rather than by reduced insulin action.
In summary, in Japanese-Brazilians, a population with 
a high prevalence of type 2 diabetes, common TCF7L2 
variants did not make a major contribution to the incidence 
of glucose tolerance abnormalities.
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